Teriflunomide is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals Ny Llc. The primary component is Teriflunomide.
Product ID | 69238-1304_3cdb678e-3c0f-4331-a8d7-288741384e32 |
NDC | 69238-1304 |
Product Type | Human Prescription Drug |
Proprietary Name | Teriflunomide |
Generic Name | Teriflunomide |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2018-10-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA209613 |
Labeler Name | Amneal Pharmaceuticals NY LLC |
Substance Name | TERIFLUNOMIDE |
Active Ingredient Strength | 14 mg/1 |
Pharm Classes | Pyrimidine Synthesis Inhibitor [EPC],Dihydroorotate Dehydrogenase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2018-10-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA209613 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-10-01 |
Marketing Category | ANDA |
Application Number | ANDA209613 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-10-01 |
Ingredient | Strength |
---|---|
TERIFLUNOMIDE | 14 mg/1 |
SPL SET ID: | 1f054d91-aede-4c1a-9aba-04f40d11e4d1 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0115-1565 | Teriflunomide | Teriflunomide |
68462-311 | teriflunomide | teriflunomide |
68462-312 | teriflunomide | teriflunomide |
69238-1303 | Teriflunomide | Teriflunomide |
69238-1304 | Teriflunomide | Teriflunomide |
69539-032 | Teriflunomide | Teriflunomide |
69539-033 | Teriflunomide | Teriflunomide |
58468-0210 | Aubagio | teriflunomide |
58468-0211 | Aubagio | teriflunomide |